Skip to main content
Martha Sajatovic, MD, Psychiatry, Cleveland, OH

Martha Sajatovic MD

Psychiatry•Cleveland, OH

Director, Neurological and Behavioral Outcomes Center, UH Cleveland Medical Center; Director, Geropsychiatry Program, UH Cleveland Medical Center; Professor, Psychiatry, CWRU School of Medicine

Join to view full profile

  • 11100 Euclid AveCleveland, OH 44106

  • Phone+1 216-844-2400

  • Fax+1 216-844-1703

Dr. Sajatovic is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Sajatovic's full profileAlready have an account?

Education & Training

  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Psychiatry, 1986 - 1990
  • The University of Toledo College of Medicine
    The University of Toledo College of MedicineClass of 1986

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 1988 - 2028
  • Psychiatry
    American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2016-2017
  • CMS Meaningful Use Stage 1 Certification Allscripts FollowMyHealth, Allscripts, 2016-2017

Clinical Trials

Publications & Presentations

PubMed

Other

Press Mentions

  • Valbenazine Effective for Long-Term Treatment of TD in Older Adults, Analysis Finds
    Valbenazine Effective for Long-Term Treatment of TD in Older Adults, Analysis FindsMay 21st, 2025
  • Q&A: Medical, Psychiatric Comorbidities Common in New-Onset & Incident Epilepsy
    Q&A: Medical, Psychiatric Comorbidities Common in New-Onset & Incident EpilepsyDecember 2nd, 2024
  • Teva Announces Post Hoc Analysis of Long-Term Data Examining Treatment with AUSTEDO® (Deutetrabenazine) Tablets in Adult Patients with Tardive Dyskinesia
    Teva Announces Post Hoc Analysis of Long-Term Data Examining Treatment with AUSTEDO® (Deutetrabenazine) Tablets in Adult Patients with Tardive DyskinesiaAugust 20th, 2021

Grant Support

  • Self-management Intervention for Reducing Epilepsy Burden among Ugandans with EpilepsyMAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES2023–2028
  • Self-management Intervention for Reducing Epilepsy Burden among Ugandans with EpilepsyMAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES2023–2028
  • A Targeted Self-Management Intervention for Reducing Stroke Risk Factors in High Risk UgandansCASE WESTERN RESERVE UNIVERSITY2020–2026
  • Research training and mentorship to strengthen brain health across the lifespan in Uganda.MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES2020–2025
  • Effectiveness RCT of Customized Adherence EnhancementCASE WESTERN RESERVE UNIVERSITY2020–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Martha Sajatovic, Dr. Martha Sajatovic, MD, Dr. M Sajatovic